Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

FG has no added value in prediction of mortality after partial and radical nephrectomy for chromophobe renal cell carcinoma patients.

FG has no added value in prediction of mortality after partial and radical nephrectomy for chromophobe renal cell carcinoma patients. Mod Pathol. 2013 Aug; 26(8):1152.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.